Cargando…
Antioxidants and mucosa protectives: realistic therapeutic options in inflammatory bowel disease?
Oxidative damage is involved in the pathogenic process of idiopathic chronic inflammatory bowel disease. Although specific intervention in the oxidative cascade showed promising results in animal models and preliminary patient trials, the clinical efficacy of antioxidants still has to be established...
Autores principales: | Kruidenier, L, Verspaget, H W |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
1998
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1781836/ https://www.ncbi.nlm.nih.gov/pubmed/9705602 |
Ejemplares similares
-
Emerging therapeutic options in inflammatory bowel disease
por: Yamamoto-Furusho, Jesus K, et al.
Publicado: (2021) -
New treatment options for inflammatory bowel diseases
por: Verstockt, Bram, et al.
Publicado: (2018) -
Cytokine production profile in intestinal mucosa of paediatric inflammatory bowel disease
por: Vitale, Serena, et al.
Publicado: (2017) -
WISP1 Is Increased in Intestinal Mucosa and Contributes to Inflammatory Cascades in Inflammatory Bowel Disease
por: Zhang, Qi, et al.
Publicado: (2016) -
Can control of gut microbiota be a future therapeutic option for inflammatory bowel disease?
por: Nishida, Atsushi, et al.
Publicado: (2021)